27.07.20151570
Women with Fontan circulation can successfully complete pregnancy, but an increase in cardiac and neonatal morbidity exists, results by French researchers published in the International Journal of Cardiology show.
24.07.20151393
The FDA and Sanofi/Regeneron announced that the agency has approved alirocumab, a PCSK9 inhibitor, for lowering of LDL in addition to diet and maximally tolerated statin therapy in patients with heterozygous familial hypercholesterolemia or those with clinical atherosclerotic CVD.
23.07.20151265
Dislipidemia in type 2 diabetes mellitus contributes to arterial endothelial dysfunction and an increased risk of cardiovascular disease.
22.07.20151446
The drug, to be marketed as Repatha (Amgen), is the first PCSK9 inhibitor to be approved for intensive reduction of LDL, according to a company press release.
21.07.20151421
Patients with psoriasis, and particularly those with psoriatic arthritis, were at increased risk of developing arrhythmia, independent of traditional cardiovascular risk factors, according to recently published study results.
21.07.20151380
To participate in the expertise scientist has to be registered in the Science Index as author of scientific articles, an academic degree and total number of citations for 5 years (2009-2013) not less than fixed (different for each research field).
20.07.20151737
Stroke frequently complicates infective endocarditis (IE). However, the temporal relationship between these diseases is uncertain.